Skip to content

The efficacy of acupuncture on chemotherapy-induced peripheral neuropathy receiving standard treatment in patients with breast cancer

The efficacy of acupuncture on chemotherapy-induced peripheral neuropathy receiving standard treatment in patients with breast cancer: a prospective, randomized controlled, assessor-blinded, pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008943
Enrollment
56
Registered
2023-11-10
Start date
2023-07-03
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The experimental group will receive 8 sessions of acupuncture treatment over 4 weeks and for 30 minutes per session, whereas the control group will not receive acupuncture treatmen

Sponsors

Kyung Hee University Oriental Medicine Hospital at Gangdong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • aged = 19 years old • histologically confirmed stage I~III breast cancer • completed neoadjuvant or adjuvant taxane-based chemotherapy • the average severity of CIPN is moderate to severe (NRS ?4) • started standard treatment (Duloxetine) for CIPN within a month. • ECOG ?3 • life expenctancy more than six months • signed informed consent

Exclusion criteria

Exclusion criteria: • receiving chemotherapy. • diagnosed with diabetic neuropathy. • diagnosed with neuropathy from any type of nerve compression • suspected alcohol or drug abuse • having received acupuncture treatment in the past one month • severe hemorrhagic coagulopathy or bleeding tendency. • pregnant, lactating, or planning to be pregnant • any other condition that the researcher considers to be inappropriate

Design outcomes

Primary

MeasureTime frame
BPI-SF average pain severity

Secondary

MeasureTime frame
BPI-SF average pain severity;Functional Assessment of Cancer Therapy/Gynecologic Oncology Group – Neurotoxicity (FACT/GOC-NTX);Beck Depression Inventory-II (BDI-II);Brief Fatigue Inventory (BFI)

Countries

Korea, Republic of

Contacts

Public ContactHayun Jin

Kyung Hee University Oriental Medicine Hospital at Gangdong

jhayun@khu.ac.kr+82-2-440-7272

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026